Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

09/08/2019 07:01

Aug 9 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               28.41               25.49           111.00    
                   (+11.4 pct)         (+13.2 pct)      (+5.6 pct)  
  Operating            5.21                3.50            14.50    
                   (+48.8 pct)         (+47.3 pct)      (-9.2 pct)  
  Recurring            5.28                4.81            14.60    
                   (+9.9 pct)          (+64.1 pct)      (-22.6 pct) 
  Net                  3.76                3.57            10.40    
                   (+5.6 pct)          (+77.8 pct)      (-22.8 pct) 
  EPS               76.51 yen           72.47 yen       211.34 yen  
  EPS Diluted       70.77 yen           67.04 yen                   
  Ann Div                              107.50 yen        44.00 yen  
  -Q2 div                               47.50 yen        22.00 yen  
  -Q4 div                               60.00 yen        22.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T